Venture
EdenRoc Sciences LLC
Latest Form D 2024-11-15- CIK 1685567
- State MI
- Biotechnology
- 10 Form D offerings since 2016-09-29
- Total sold
- $220M
- across 10 offerings
- Rounds
- 10
- Form D offerings since 2016-09-29
- Latest round
- $2.8M
- 2024-11-15 · 021-529496
- Investors
- 3
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2024-11-15 · $2.8M
- 2016-09-29$30M021-271500
- 2017-07-26$15M021-291546
- 2018-03-19$15M021-307986
- 2019-02-20$13.5M021-333139
- 2019-07-30$8M021-345399
- 2020-07-31$17.6M021-372191
- 2021-11-03$18M021-419718
- 2021-11-03$35.9M021-419720
- 2023-12-26$64.2M021-500753
- 2024-11-15$2.8M021-529496
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($64.2M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-529496 | First filed2024-11-15 | Latest2024-11-15 | Sought$50M | Sold$2.8M | Investors3 | Exemptions506(b) |
| 021-500753 | First filed2023-12-26 | Latest2024-07-16 | Sought$64.2M | Sold$64.2M | Investors50 | Exemptions506(b) |
| 021-419720 | First filed2021-11-03 | Latest2022-05-24 | Sought$35.9M | Sold$35.9M | Investors22 | Exemptions506(b) |
| 021-419718 | First filed2021-11-03 | Latest2021-11-03 | Sought$18M | Sold$18M | Investors10 | Exemptions506(b) |
| 021-372191 | First filed2020-07-31 | Latest2020-07-31 | SoughtIndefinite | Sold$17.6M | Investors11 | Exemptions506(b) |
| 021-345399 | First filed2019-07-30 | Latest2019-07-30 | Sought$47.5M | Sold$8M | Investors4 | Exemptions506(b) |
| 021-333139 | First filed2019-02-20 | Latest2019-02-20 | Sought$13.5M | Sold$13.5M | Investors4 | Exemptions506(b) |
| 021-307986 | First filed2018-03-19 | Latest2018-03-19 | Sought$15M | Sold$15M | Investors2 | Exemptions506(b) |
| 021-291546 | First filed2017-07-26 | Latest2017-07-26 | Sought$15M | Sold$15M | Investors3 | Exemptions506(b) |
| 021-271500 | First filed2016-09-29 | Latest2016-09-29 | Sought$30M | Sold$30M | Investors1 | Exemptions506(b) |
Who backs EdenRoc Sciences LLC, inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-11-15
| Name | Relationship |
|---|---|
| Edward Schulak | RelationshipExecutive Officer, Director |
| Mathew Easterday | RelationshipExecutive Officer |
| David Sinclair | RelationshipDirector |
| Christopher Wibbleman | RelationshipDirector |
| Todd Dickinson | RelationshipDirector |
| J. Taylor Crandall | RelationshipDirector |
| Christopher McDoniel | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Michigan (MI)
- Exemptions
- Rule 506(b)
- First filed
- 2016-09-29
- Latest filing
- 2024-11-15
Who backs EdenRoc Sciences LLC
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗